Nuzenio

Tradingview Vanda Pharmaceuticals

Tradingview Vanda Pharmaceuticals entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Vanda Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 07:03:59 GMTVNDA: Fanapt and NEREUS drive growth as BYSANTI approval and pipeline advances set stage for expansion - TradingViewTradingView · Wed, 05 Aug 2026 21:47:32 GMTVanda Pharmaceuticals Q2 loss widens on lower sales, higher costs - TradingViewTradingView · Wed, 05 Aug 2026 20:10:29 GMTVNDA: Q2 2026 saw revenue fall 4% and a net loss of $62.5M, with HETLIOZ® sales down 66% and Fanapt® up 23% - TradingViewTradingView · Wed, 05 Aug 2026 11:40:20 GMTVNDA Q2'26 Earnings: EPS estimate is (0.58) USD - TradingViewTradingView · Tue, 04 Aug 2026 11:01:30 GMTVanda Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 5, 2026 - TradingViewTradingView · Wed, 29 Jul 2026 20:31:00 GMTVNDA Q2'26 Earnings: revenue estimate is 61.92M USD - TradingViewTradingView · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 07:03:59 GMTVanda Pharmaceuticals Q2 Earnings Call Highlights - TradingView
Wed, 05 Aug 2026 21:47:32 GMTVNDA: Fanapt and NEREUS drive growth as BYSANTI approval and pipeline advances set stage for expansion - TradingView
Wed, 05 Aug 2026 20:10:29 GMTVanda Pharmaceuticals Q2 loss widens on lower sales, higher costs - TradingView
Wed, 05 Aug 2026 11:40:20 GMTVNDA: Q2 2026 saw revenue fall 4% and a net loss of $62.5M, with HETLIOZ® sales down 66% and Fanapt® up 23% - TradingView
Tue, 04 Aug 2026 11:01:30 GMTVNDA Q2'26 Earnings: EPS estimate is (0.58) USD - TradingView
Wed, 29 Jul 2026 20:31:00 GMTVanda Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 5, 2026 - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Vanda Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.